The DOI matches its Crossref record; 146 of the 154 references it cites were found in a registry or an index.
Long-term effects of weight-reducing diets in people with hypertension
Open accessAbstract
BACKGROUND: All major guidelines for antihypertensive therapy recommend weight loss. Dietary interventions that aim to reduce body weight might therefore be a useful intervention to reduce blood pressure and adverse cardiovascular events associated with hypertension. OBJECTIVES: Primary objectives To assess the long-term effects of weight-reducing diets in people with hypertension on all-cause mortality, cardiovascular morbidity, and adverse events (including total serious adverse events, withdrawal due to adverse events, and total non-serious adverse events). Secondary objectives To assess the long-term effects of weight-reducing diets in people with hypertension on change from baseline in systolic blood pressure, change from baseline in diastolic blood pressure, and body weight reduction. SEARCH METHODS: For this updated review, the Cochrane Hypertension Information Specialist searched the following databases for randomised controlled trials up to April 2020: the Cochrane Hypertension Specialised Register, CENTRAL (2020, Issue 3), Ovid MEDLINE, Ovid Embase, and ClinicalTrials.gov. We also contacted authors of relevant papers about further published and unpublished work. The searches had no language restrictions. SELECTION CRITERIA: We included randomised controlled trials (RCTs) of at least 24 weeks' duration that compared weight-reducing dietary interventions to no dietary intervention in adults with primary hypertension. DATA COLLECTION AND ANALYSIS: , we used a random-effects model. MAIN RESULTS: This second review update did not reveal any new trials, so the number of included trials remains the same: eight RCTs involving a total of 2100 participants with high blood pressure and a mean age of 45 to 66 years. Mean treatment duration was 6 to 36 months. We judged the risks of bias as unclear or high for all but two trials. No study included mortality as a predefined outcome. One RCT evaluated the effects of dietary weight loss on a combined endpoint consisting of the necessity of reinstating antihypertensive therapy and severe cardiovascular complications. In this RCT, weight-reducing diet lowered the endpoint compared to no diet: hazard ratio 0.70 (95% confidence interval (CI) 0.57 to 0.87). None of the trials evaluated adverse events as designated in our protocol. The certainty of the evidence was low for a blood pressure reduction in participants assigned to weight-loss diets as compared to controls: systolic blood pressure: mean difference (MD) -4.5 mm Hg (95% CI -7.2 to -1.8 mm Hg) (3 studies, 731 participants), and diastolic blood pressure: MD -3.2 mm Hg (95% CI -4.8 to -1.5 mm Hg) (3 studies, 731 participants). We judged the certainty of the evidence to be high for weight reduction in dietary weight loss groups as compared to controls: MD -4.0 kg (95% CI -4.8 to -3.2) (5 trials, 880 participants). Two trials used withdrawal of antihypertensive medication as their primary outcome. Even though we did not consider this a relevant outcome for our review, the results of these RCTs strengthen the finding of a reduction of blood pressure by dietary weight-loss interventions. AUTHORS' CONCLUSIONS: In this second update, the conclusions remain unchanged, as we found no new trials. In people with primary hypertension, weight-loss diets reduced body weight and blood pressure, but the magnitude of the effects are uncertain due to the small number of participants and studies included in the analyses. Whether weight loss reduces mortality and morbidity is unknown. No useful information on adverse effects was reported in the relevant trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Weight-reducing diets are well established to lower BP among patients with hypertension, by 4.5/3.2 mm Hg in the most recent meta-analysis.347”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [347]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Research works printed but not linked: 76
- Anderssen, 1995, Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES), Blood Pressure, 4, 343, 10.3109/08037059509077619 · DOI
- Anderssen, 1996, Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial, Journal of Internal Medicine, 240, 203, 10.1046/j.1365-2796.1996.22848000.x · DOI · Paper page
- Jacobs, 2009, Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study, The American Journal of Clinical Nutrition, 89, 509, 10.3945/ajcn.2008.26371 · DOI
- Torjesen, 1997, Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial, Diabetes Care, 20, 26, 10.2337/diacare.20.1.26 · DOI
- Urdal, 1993, The Oslo Diet and Exercise Study (ODES): Design and objectives, Controlled Clinical Trials, 14, 229, 10.1016/0197-2456(93)90005-X · DOI
- Anderssen, 1995, Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES), Blood Pressure, 4, 343, 10.3109/08037059509077619 · DOI
- Anderssen, 1996, Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial, Journal of Internal Medicine, 240, 203, 10.1046/j.1365-2796.1996.22848000.x · DOI · Paper page
- Jacobs, 2009, Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study, The American Journal of Clinical Nutrition, 89, 509, 10.3945/ajcn.2008.26371 · DOI
- Torjesen, 1997, Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial, Diabetes Care, 20, 26, 10.2337/diacare.20.1.26 · DOI
- Urdal, 1993, The Oslo Diet and Exercise Study (ODES): Design and objectives, Controlled Clinical Trials, 14, 229, 10.1016/0197-2456(93)90005-X · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1993, Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension, Archives of Internal Medicine, 153, 1773, 10.1001/archinte.1993.00410150051005 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension, Archives of Internal Medicine, 152, 131, 10.1001/archinte.1992.00400130141018 · DOI
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1993, Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension, Archives of Internal Medicine, 153, 1773, 10.1001/archinte.1993.00410150051005 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension, Archives of Internal Medicine, 152, 131, 10.1001/archinte.1992.00400130141018 · DOI
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Blaufox, 1992, Renin predicts diastolic blood pressure response to nonpharmacologic and pharmacologic therapy, JAMA, 267, 1221, 10.1001/jama.1992.03480090069029 · DOI
- Davis, 1989, Trial of antihypertensive interventions and management. Design, methods, and selected baseline results, Controlled Clinical Trials, 10, 11, 10.1016/0197-2456(89)90016-0 · DOI
- Davis, 1993, Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension, Archives of Internal Medicine, 153, 1773, 10.1001/archinte.1993.00410150051005 · DOI
- Davis, 1992, Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group, Hypertension, 19, 393, 10.1161/01.HYP.19.4.393 · DOI
- Davis, 1994, Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management, American Journal of Hypertension, 7, 926, 10.1093/ajh/7.10.926 · DOI
- Langford, 1991, Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group, Hypertension, 17, 210, 10.1161/01.HYP.17.2.210 · DOI
- Oberman, 1990, Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status, Annals of Internal Medicine, 112, 89, 10.7326/0003-4819-112-2-89 · DOI
- Wassertheil-Smoller, 1994, The trial of antihypertensive interventions and management (TAIM), Nieren- und Hochdruckkrankheiten, 23 (Suppl 1), S22
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension, Archives of Internal Medicine, 152, 131, 10.1001/archinte.1992.00400130141018 · DOI
- Wassertheil-Smoller, 1991, The TAIM Study: Sex-race differences in effects of diet and drugs on cardiovascular risk, Cardiovascular Risk Factors, 1, 427
- Wassertheil-Smoller, 1992, The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life, American Journal of Hypertension, 5, 37, 10.1093/ajh/5.1.37 · DOI
- Wylie-Rosett, 1993, Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention, Journal of the American Dietetic Association, 93, 408, 10.1016/0002-8223(93)92286-7 · DOI
- Bahnson, 1997, Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE), Disease Management & Clinical Outcomes, 1, 61, 10.1016/S1088-3371(97)00005-3 · DOI
- Fessler, 1998, Sodium reduction and weight loss instead of treatment with antihypertensive agents. [German], Deutsche Apotheker Zeitung, 138, 36
- Hypertension Prevention Collaborative Research Group, 1993, The impact of weight loss on blood pressure, Patient Care, 27, 16
- Angelico, 2009, Low-fat, low-calorie, Mediterranean-style diet improves endothelial dysfunction in patients with the metabolic syndrome, Journal of Diabetes, 1, A43
- Appel, 2006, The effects of macronutrient intake on blood pressure: Subgroup analyses from the OmniHeart randomized feeding study, Journal of Hypertension, 24, 177
- Bao, 1999, Dietary fish and weight reduction improves multiple risk factors in overweight, treated hypertensives. [abstract], Australian & New Zealand Journal of Medicine, 29, 148
- Bouchonville, 2012, Weight Loss, Exercise, or Both and Cardiometabolic Risk Factors in Obese Older Adults: Results of a Randomized Controlled Trial, Endocrine Reviews, 33, S18, 10.1038/ijo.2013.122 · DOI · Paper page
- Cambien, 1986, Comparative study of a medical and a dietary intervention in overweight hypertensive patients, Archives des Maladies du Coeur et des Vaisseaux, 79, 1002
- Ebell, 2013, Intensive lifestyle intervention fails to improve patient-oriented outcomes in persons with obesity and diabetes, American Family Physician, 88, 864A
- Hayward, 2010, Lifestyle modification and NAFLD: A prospective, randomized trial, Hepatology, 52, 622A
- Masuo, 2012, The effects of weight loss on liver function in obese hypertensive patients, Circulation, 125, P131
- McCarron, 2000, Cardiovascular risk reduction dietary intervention trial, Drug Benefit Trends, 12, 42
- Tate, 2011, Replacing caloric beverages with water or diet beverages for weight loss in adults: Results of a 6-month randomized controlled trial, Obesity, 19, S68
- Tunyan, 2007, Cardioprotective effects of antihypertensive therapy with orlistat treatment and hypocaloric diet in combination in obese hypertensive patients, Circulation, 115, e248
- Anderssen, 1995, Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES), Blood Pressure, 4, 343, 10.3109/08037059509077619 · DOI
- Haynes B RE: Cochrane Review [personal communication] Email to: A Siebenhofer.
- The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014
- Urdal, 1993, The Oslo Diet and Exercise Study (ODES): Design and objectives, Controlled Clinical Trials, 14, 229, 10.1016/0197-2456(93)90005-X · DOI
Cited by
Sorted by citations
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Gomes, M. A. M., Brandão, A. A., Feitosa, A. D. M., Machado, C. A., Poli‐de‐Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,389
Diabetes and hypertension: a position statement by the American Diabetes Association
de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G. (2017) · Diabetes Care · doi:10.2337/dci17-0026 · Cited by 714
“The loss of 1 kg in body weight has been associated with a decrease in blood pressure of;1 mmHg (60).”
BackgroundRoerecke, M., Kaczorowski, J., Tobe, S. W., Gmel, G., Hasan, O. S. M., & Rehm, J. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30003-8 · Cited by 552
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., de Oliveira, G. M. M., Simão, A. F. L., Dutra, Ó. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R., Giuliano, I. D. C. B., Filho, A. C. D. A., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 507
Lifestyle interventions for the prevention and treatment of hypertension
Valenzuela, P. L., Carrera‐Bastos, P., Gálvez, B. G., Ruiz‐Hurtado, G., Ordovás, J. M., Ruilope, L. M., & Lucía, A. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00437-9 · Cited by 400
Leggio, M., Lombardi, M., Caldarone, E., Severi, P., D’Emidio, S., Armeni, M., Bravi, V., Bendini, M. G., & Mazza, A. (2017) · Hypertension Research · doi:10.1038/hr.2017.75 · Cited by 319
Charchar, F. J., Prestes, P. R., Mills, C. E., Ching, S. M., Neupane, D., Marques, F. Z., Sharman, J. E., Vogt, L., Burrell, L. M., Коростовцева, Л. С., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003563 · Cited by 394
“The paramount [50].”
Hall, M. E., Cohen, J. B., Ard, J. D., Egan, B. M., Hall, J. E., Lavie, C. J., Ma, J., Ndumele, C. E., Schauer, P. R., & Shimbo, D. (2021) · Hypertension · doi:10.1161/hyp.0000000000000202 · Cited by 259
Altered dietary salt intake for people with chronic kidney disease
McMahon, E., Campbell, K., Bauer, J., & Mudge, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010070.pub2 · Cited by 198
García, J. F. C., Roncero‐Martín, R., Rico‐Martín, S., Jiménez, J. M., López‐Espuela, F., Santano‐Mogena, E., Alfageme-García, P., & Muñoz-Torrero, J. F. S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111607 · Cited by 174
“The degree of the effect of behavioural weight loss on BP has been examined previously in a meta-analysis of eight clinical trials that involved a total of 2100 hypertensive patients [60], where the mean reduction in systolic/diastolic BP was 4.”
Dietary Factors and Risks of Cardiovascular Diseases: An Umbrella Review
Chareonrungrueangchai, K., Wongkawinwoot, K., Anothaisintawee, T., & Reutrakul, S. (2020) · Nutrients · doi:10.3390/nu12041088 · Cited by 173
“consumption of fish, vegetables, complex carbohydrates, and fiber (two SRMA) [17,19].”
BackgroundMethodMechanisms of weight loss and improved metabolism following bariatric surgery
Mulla, C. M., Middelbeek, R. J. W., & Patti, M. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13409 · Cited by 161
Gaesser, G. A., & Angadi, S. S. (2021) · iScience · doi:10.1016/j.isci.2021.102995 · Cited by 170
Najjar, R. S., Moore, C. E., & Montgomery, B. D. (2018) · Clinical Cardiology · doi:10.1002/clc.22863 · Cited by 117
“5-mmHg and 3-mmHg reduction in SBP and DBP, respectively.(18) Results from this review would underestimate expected outcomes of this trial.”
ResultImproving obesity and blood pressure
Tanaka, M. (2019) · Hypertension Research · doi:10.1038/s41440-019-0348-x · Cited by 113
Altered dietary salt intake for people with chronic kidney disease
McMahon, E., Campbell, K. L., Bauer, J. D., Mudge, D. W., & Kelly, J. T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010070.pub3 · Cited by 101
Digital Therapeutics in Hypertension: Evidence and Perspectives
Kario, K., Harada, N., & Okura, A. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19414 · Cited by 104
Badimón, L., Bugiardini, R., Cenko, E., Cubedo, J., Dorobanţu, M., Duncker, D. J., Estruch, R., Miličić, D., Tousoulis, D., Vasiljević, Z., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx181 · Cited by 89
“However, long-term adherence to low-fat diets is limited(56) and for those who lost weight, gain relapses usually occur after 6– 12 months.(57) In addition, a meta-analysis comparing low- vs.”
BackgroundValidation of obesity‐related diagnosis codes in claims data
Suissa, K., Schneeweiss, S., Lin, K. J., Brill, G., Kim, S. C., & Patorno, E. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14512 · Cited by 89
Dietary Intervention to Improve Blood Pressure Control: Beyond Salt Restriction
Cicero, A. F. G., Veronesi, M., & Fogacci, F. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00474-6 · Cited by 90
Oxidative and inflammatory signals in obesity-associated vascular abnormalities
Reho, J. J., & Rahmouni, K. (2017) · Clinical Science · doi:10.1042/cs20170219 · Cited by 78
Weight Loss Medications in the Treatment of Obesity and Hypertension
Cohen, J. B., & Gadde, K. M. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0915-1 · Cited by 81
Kaneko, H., Itoh, H., Yotsumoto, H., Kiriyama, H., Kamon, T., Fujiu, K., Morita, K., Michihata, N., Jo, T., Takeda, N., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017963 · Cited by 74
Diabetes and cardiovascular disease: inter-relation of risk factors and treatment
Sharma, A., Mittal, S., Aggarwal, R., & Chauhan, M. K. (2020) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-020-00151-w · Cited by 83
Recognition and Management of Resistant Hypertension
Braam, B. G., Taler, S. J., Rahman, M., Fillaus, J. A., Greco, B., Forman, J. P., Reisin, E., Cohen, D. L., Saklayen, M. G., & Hedayati, S. S. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06180616 · Cited by 73
“However, hard outcomes were not studied in any of the included trials (50).”
BackgroundMameli, C., Zuccotti, G., Carnovale, C., Galli, E., Nannini, P., Cervia, D., & Perrotta, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.017 · Cited by 63
Diagnosis and management of resistant hypertension
Schiffrin, E. L., & Fisher, N. D. L. (2024) · BMJ · doi:10.1136/bmj-2023-079108 · Cited by 64
Mattei, Â. T., Mantovani, M. D. F., Moreira, R. C., Arthur, J. P., & de Souza, R. M. (2019) · Research in Nursing & Health · doi:10.1002/nur.21994 · Cited by 59
Treatment of Obesity in Mitigating Metabolic Risk
Heffron, S. P., Parham, J. S., Pendse, J., & Alemán, J. O. (2020) · Circulation Research · doi:10.1161/circresaha.119.315897 · Cited by 62
Lopez, P. D., Cativo, E. H., Atlas, S. A., & Rosendorff, C. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.01.044 · Cited by 60
The Burden of Resistant Hypertension Across the World
Brant, L. C. C., Passaglia, L. G., Filho, M. M. P., de Castilho, F. M., Ribeiro, A. L. P., & Nascimento, B. R. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01173-w · Cited by 57
Goupil, R., Tsuyuki, R. T., Santesso, N., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770 · Cited by 60
“53 Weight-reducing medications such as glucagon-like peptide 1 receptor agonists are also effective in improving BP.”
Kennedy, C., Hayes, P. C., Salama, S., Hennessy, M., & Fogacci, F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030772 · Cited by 52
“A recently updated Cochrane review of weight loss diets in populations with hypertension identified eight trials with 2100 participants on which to base their analysis [25].”
Wang, M., Brage, S., Sharp, S. J., Luo, S., Yeung, S. L. A., & Kim, Y. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac135 · Cited by 48
Cífková, R., Fodor, G. J., & Wohlfahrt, P. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0669-y · Cited by 48
Long-term effects of weight-reducing diets in people with hypertension
Semlitsch, T., Krenn, C., Jeitler, K., Berghold, A., Horvath, K., & Siebenhofer, A. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008274.pub4 · Cited by 47
“Since our last search for dietary interventions performed in February/March 2015 (Semlitsch 2016), we could identify no additional trials addressing our research question.”
BackgroundSelf-citationHu, M., Cai, X., Yang, W., Zhang, S., Nie, L., & Ji, L. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015323 · Cited by 46
Effects of different weight loss approaches on CVD risk
Clifton, P. M., & Keogh, J. B. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0728-8 · Cited by 36
Dhungana, R. R., Pedišić, Ž., & de Courten, M. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01884-8 · Cited by 42
“Although restrictive diets are associated with a reduction in blood pressure [105–107], very little is known about their long-term impact on other aspects of health of people with hypertension [105].”
BackgroundFeng, Q., Yang, Z., May, M., Tsoi, K. K. F., Ingle, S. M., Lee, E. K. P., Wong, S. Y. S., & Kim, J. H. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.08.051 · Cited by 33
Pharmacotherapy of Obesity: Limits and Perspectives
Rosa-Gonçalves, P., & Majerowicz, D. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00328-6 · Cited by 33
Kario, K., Nomura, A., Harada, N., Tanigawa, T., So, R., Nakagawa, K., Suzuki, S., Okura, A., Hida, E., & Satake, K. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13993 · Cited by 32
Sweazea, K. L., Johnston, C. S., Miller, B., & Gumpricht, E. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/1729653 · Cited by 29
Francisco, S. C., Araújo, L. F., Griep, R. H., Chor, D., Molina, M. D. C. B., Mil, J. G., Benseñor, I. M., Matos, S. M. A., Barreto, S. M., & Giatti, L. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520000124 · Cited by 33
“may also contribute to optimal BP levels, since excess weight is related to increased BP and incidence of hypertension(25,26).”
BackgroundComparison of lifestyle changes and pharmacological treatment on cardiovascular risk factors
Marques-Vidal, P. M. (2020) · Heart · doi:10.1136/heartjnl-2019-316252 · Cited by 27
Giummarra, M. J., Tardif, H. P., Blanchard, M. B., Tonkin, A. M., & Arnold, C. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228173 · Cited by 24
“Cognitive-behavioural and lifestyle-focussed interventions can successfully improve activity capacity and fitness, and reduce activity avoidance [55], while also reducing excess body weight [56], through gradual increases in physical therapy and activity pacing.”
BackgroundHagan, S., & Nelson, K. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07821-w · Cited by 26
Lønnebakken, M. T., Mancusi, C., Losi, M. A., Gerdts, E., Izzo, R., Manzi, M. V., LUCA, N. D., SIMONE, G. D., & Trimarco, B. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.10.010 · Cited by 22
Faconti, L., George, J., Partridge, S., Maniero, C., Sathyanarayanan, A., Kulkarni, S., Kapil, V., Petrosino, A., Lewis, P., McCormack, T., et al. (2024) · Journal of Human Hypertension · doi:10.1038/s41371-024-00983-6 · Cited by 23
Resistant Hypertension Updated Guidelines
Chernova, I., & Krishnan, N. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1209-6 · Cited by 21
Wijkman, M. O., Dena, M., Dahlqvist, S., Sofizadeh, S., Hirsch, I. B., Tuomilehto, J. O., Mårtensson, J., Torffvit, O., Imberg, H., Saeed, A., et al. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13447 · Cited by 18
Liu, X., Byrd, J. B., & Rodríguez, C. J. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13203 · Cited by 16
Leibowitz, A., Grossman, E., Berkovitch, A., Levartovsky, M., Appel, S., Sharabi, Y., & Gluck, I. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx158 · Cited by 17
Daugaard, C. L., Henriksen, M., Riis, R., Bandak, E., Nybing, J. D., Hangaard, S., Bliddal, H., & Boesen, M. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.02.837 · Cited by 17
Simpson, H., Clement, N. D., Simpson, S. A., Pandit, H., Smillie, S., Leeds, A., Conaghan, P. G., Kingsbury, S. R., Hamilton, D. F., Craig, P., et al. (2024) · The Lancet Rheumatology · doi:10.1016/s2665-9913(23)00337-5 · Cited by 15
He, C., Fei, Y.-P., Zhu, C., Yao, M., Qian, G., Hu, H., & Zhai, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.750714 · Cited by 15
“have shown that continuous weight-loss diets reduced body weight and BP in individuals with primary hypertension (17).”
BackgroundEffect of Intentional Weight Loss on Mortality Biomarkers in Older Adults With Obesity
Roe, L. S., Beavers, D. P., Kiel, J., Kritchevsky, S. B., & Beavers, K. M. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly192 · Cited by 13
Waldman, H. S., Smith, J. W., Lamberth, J., Fountain, B. J., & McAllister, M. J. (2019) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000003354 · Cited by 16
“007) are in agreement with previous studies which found weight reductions of 2–4 kg also resulted in decreases of almost 5 mm Hg in both SBP andDBP (41,42).”
ResultBoeing, H., Amini, A. M., Haardt, J., Schmidt, A., Bischoff-Ferrari, H. A., Buyken, A. E., Egert, S., Ellinger, S., Kroke, A., Stefan Lorkowski, A., et al. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03336-8 · Cited by 14
Hirata, T., Kogure, M., Tsuchiya, N., Miyagawa, K., Narita, A., Nochioka, K., Uruno, A., Obara, T., Nakamura, T., Nakaya, N., et al. (2021) · Hypertension Research · doi:10.1038/s41440-021-00628-y · Cited by 12
Gaesser, G. A. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2311364 · Cited by 13
Itoh, H., Kaneko, H., Kiriyama, H., Nakanishi, K., Mizuno, Y., Daimon, M., Morita, H., Yamamichi, N., & Komuro, I. (2019) · International Heart Journal · doi:10.1536/ihj.19-314 · Cited by 11
Hisaki, F., Aga, M., Tomitani, N., Okawara, Y., Harada, N., & Kario, K. (2023) · Hypertension Research · doi:10.1038/s41440-023-01434-4 · Cited by 11
“The management of hypertension signi fi cantly bene fi ts from targeted interventions such as salt reduction [9] and weight reduction [10].”
Wang, F., & Wang, X. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-12698-z · Cited by 11
Chattranukulchai, P., Roubsanthisuk, W., Kunanon, S., Kotruchin, P., Satirapoj, B., Wongpraparut, N., Sunthornyothin, S., & Sukonthasarn, A. (2024) · Hypertension Research · doi:10.1038/s41440-024-01785-6 · Cited by 11
“Weight reduction through diet control is well-established to lower BP among patients with hypertension [23].”
BackgroundMethodAhmadi, S., Sajjadi, H., Nejad, F. N., Ahmadi, N., Karimi, S. E., Yoosefi, M., & Rafiey, H. (2019) · PubMed Central · doi:10.34171/mjiri.33.43 · Cited by 9
Nonpharmacological Management of Resistant Hypertension
Sabbahi, A., Severin, R. S., Laddu, D., Sharman, J. E., Arena, R. A., & Ozemek, C. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01601-4 · Cited by 9
Shoenbill, K., Song, Y.-Q., Craven, M., Johnson, H., Smith, M. A., & Mendonça, E. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106061 · Cited by 9
Bonten, T. N., Verkleij, S., van der Kleij, R., Busch, K., van den Hout, W. B., Chavannes, N. H., & Numans, M. E. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043829 · Cited by 7
Blood Pressure-Lowering Therapy
Sudano, I., Osto, E., & Ruschitzka, F. T. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_372 · Cited by 7
“Indeed, the overall efficacy of lifestyle interventions in reducing cardiovascular outcomes has been questioned by the results of the Action for Health in Diabetes (Look AHEAD) Study (Look, Ahead Research Group et al. 2013; Semlitsch et al. 2016).”
BackgroundKamal, M. S. A., Ismail, N. H., Satar, N. A., Azis, N. A., Radjeni, Z., Noor, H. S. M., Kasim, N., & Singh, H. J. (2019) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2018.1506467 · Cited by 6
“Body weight is known to influence blood pressure, where higher blood pressure is often recorded in overweight and obese individuals (24–26) and body weight loss is associated with decreased blood pressure (27,28).”
BackgroundWhich is more effective in hypertension?: Salt-free diet vs DASH diet
Çapar, A. G., & Yılmaz, M. (2025) · Medicine · doi:10.1097/md.0000000000041636 · Cited by 5
“[4,5] It has been discovered that among the DASH diets with varying sodium levels, the low sodium DASH diet has a greater lowering effect on SBP, DBP and also reduces the urinary sodium and potassium excretion rate.”
Shobako, N., Goto, C., Nakagawa, T., Yamato, T., Kondo, S., Nakamura, F., Nakazeko, T., Hirano, Y., & Honda, K. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105279 · Cited by 6
Behavioral Interventions in Hypertension: A Lifestyle Medicine Approach
Wani, R. T., Khader, K., & Udawat, P. (2023) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_672_23 · Cited by 5
Ersoy, C., & Ersoy, A. (2019) · Turkish Journal of Internal Medicine · doi:10.46310/tjim.634597 · Cited by 5
Bhagavathula, A. S., Shah, S. M. A., Suliman, A., Oulhaj, A., & Aburawi, E. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010047 · Cited by 5
Ahmadi, S., Sajjadi, H., Nejad, F. N., Ahmadi, N., Karimi, S. E., Yoosefi, M., & Rafiey, H. (2019) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.33.43 · Cited by 4
Odaguchi, N., Sakima, A., & Nakada, S. (2020) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2020.1860079 · Cited by 3
Obesity and Hypertension: Pathophysiology and Treatment
Hall, M. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., & Hall, J. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00037-2 · Cited by 3
A review on the current drugs and new targets for obesity
Poojashree, M. J. (2020) · Journal of Applied Pharmaceutical Research · doi:10.18231/j.joapr.2019.v.8.i.1.002 · Cited by 3
Ghazi, L., Dubal, M., Bertoni, A. G., Carson, A. P., Young, B. A., Lewis, C. E., Alanaeme, C. J., Johnson, D. A., Shimbo, D., Foti, K. E., et al. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-01078-6 · Cited by 2
“Hypertension is a common metabolic risk factor among United States adults, and its prevalence is a higher among adults with versus without obesity.”
Lemp, J. M., Pengpid, S., Buntup, D., Bärnighausen, T., Geldsetzer, P., Peltzer, K., Rehm, J. T., Sornpaisarn, B., & Probst, C. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101954 · Cited by 3
Early Markers of Cardiovascular Risk in Women With Hereditary Burdening by Cardiovascular Diseases
Stryuk, R. I., Brytkova, Y. V., Berns, S. A., Крикунов, П. В., Татаринова, О. В., Tektova, A. S., Osmanova, M. M., Иванова, Т. Б., Barkova, E., & Kozhukhovskaya, O. L. (2018) · Kardiologiia · doi:10.18087/cardio.2018.6.10133 · Cited by 2
Villarino, R. T. (2024) · SSRN Electronic Journal · doi:10.31219/osf.io/gz45w · Cited by 2
Odaguchi, N., Sakima, A., Yara, T. E. L., & Shiroma, I. (2022) · JMA Journal · doi:10.31662/jmaj.2021-0146 · Cited by 1
“0 mmHg ((19)), and a meta-analysis reported a significant reduction in BP following a weight loss of 4 kg ((20)).”
BackgroundThe inverted U-shaped relationship between weight loss percentage and cardiovascular health scores
Chen, F., Zhang, Y., & Chen, S. (2023) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-023-01619-3 · Cited by 1
Inoue, T., Matsuoka, M., Tamashiro, M., Arasaki, O., & Arima, H. (2024) · Hypertension Research · doi:10.1038/s41440-024-01921-2 · Cited by 1
“Weight reduction, in particular, provides signi fi cant anti-hypertensive bene fi ts [11, 12].”
Obesity and Hypertension: Etiology and the Effects of Diet, Bariatric Surgery, and Antiobesity Drugs
Elattar, S., Chand, S., Salem, A. M., Abdulfattah, A., Bassiony, M. A. A., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000937 · Cited by 1
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251343907 · Cited by 3
Ding, Y., Meng, R., Hu, Z., Sun, Y., Zhang, H., Wang, Y., Ma, Y., & He, Y. H. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.103563 · Cited by 2
Volpe, M., & Gallo, G. (2022) · European Heart Journal Supplements · doi:10.1093/eurheartjsupp/suac094 · Cited by 1
“2 mmHg) BP levels.(7) However, there is no evidence with regard to the benefits of specific dietary regimens in patients with resistant hypertension.”
BackgroundKiliç, B., Biermans, M. C. J., Rutten, F. H., Deinum, J., Spiering, W., van der Wel, M. C., de Grauw, W. J. C., Bots, M. L., & Hollander, M. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.107062 · Cited by 2
EARLY ECHOCARDIOGRAPHIC MARKERS OF CARDIOVASCULAR RISK IN WOMEN
Крикунов, П. В., Brytkova, Y. V., Berns, S. A., Kozhukhovskaya, O. L., & Stryuk, R. I. (2017) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2017-12-41-46 · Cited by 1
Obesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect
Owen, J., Morse, S., McLean, A., & Reisin, E. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_15 · Cited by 1
What Is New in the Non-pharmacological Approaches to Hypertension Control
Kng, K. K., & Sule, A. A. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-95734-6_8 · Cited by 1
Impedance change during intentional weight loss in Thai obese patients
Rattanachaiwong, S., Pisprasert, V., Hongsprabhas, P., Panitanarak, U., & Larphun, P. (2022) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2022.11.004 · Cited by 1
Waldman, H. S. (2019) · Mississippi State University · doi:10.54718/wwdo1938 · Cited by 1
Bala, C. G. (2019) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-93320-7_17 · Cited by 1
Metadata
- Authors
- Semlitsch, T., Jeitler, K., Berghold, A., Horvath, K., Posch, N., Poggenburg, S., & Siebenhofer, A.
- Affiliations
- Medical University of Graz (AT)
- Goethe University Frankfurt (DE)
- ORCID
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-03-02
- Volume
- 2
- Pages
- CD008274-CD008274
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC7154764
- OpenAlex
- W2290414732
- Cited by
- 118
- References
- 154
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 15 · 2021: 18 · 2020: 16 · 2019: 16 · 2018: 10 · 2017: 9 · 2016: 2
- FWCI
- 2.14
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-02-08)
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Keywords
- hypertension, weight loss diet, dietary weight loss, blood pressure reduction, cardiovascular morbidity, all-cause mortality, adverse events, weight loss, antihypertensive therapy, essential hypertension, long-term effects, cardiovascular complications, antihypertensive withdrawal, risk of bias, quality of evidence
- MeSH terms
- Aged, Blood Pressure, Cardiovascular Diseases, Diet, Reducing, Humans, Hypertension, Middle Aged, Weight Loss, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review